These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

538 related items for PubMed ID: 17032878

  • 1. Comparing perfusion metrics obtained from a single compartment versus pharmacokinetic modeling methods using dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade.
    Law M, Young R, Babb J, Rad M, Sasaki T, Zagzag D, Johnson G.
    AJNR Am J Neuroradiol; 2006 Oct; 27(9):1975-82. PubMed ID: 17032878
    [Abstract] [Full Text] [Related]

  • 2. Comparison of cerebral blood volume and vascular permeability from dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade.
    Law M, Yang S, Babb JS, Knopp EA, Golfinos JG, Zagzag D, Johnson G.
    AJNR Am J Neuroradiol; 2004 May; 25(5):746-55. PubMed ID: 15140713
    [Abstract] [Full Text] [Related]

  • 3. Dynamic contrast-enhanced and dynamic susceptibility contrast perfusion MR imaging for glioma grading: Preliminary comparison of vessel compartment and permeability parameters using hotspot and histogram analysis.
    Santarosa C, Castellano A, Conte GM, Cadioli M, Iadanza A, Terreni MR, Franzin A, Bello L, Caulo M, Falini A, Anzalone N.
    Eur J Radiol; 2016 Jun; 85(6):1147-56. PubMed ID: 27161065
    [Abstract] [Full Text] [Related]

  • 4. Histogram analysis versus region of interest analysis of dynamic susceptibility contrast perfusion MR imaging data in the grading of cerebral gliomas.
    Law M, Young R, Babb J, Pollack E, Johnson G.
    AJNR Am J Neuroradiol; 2007 Apr; 28(4):761-6. PubMed ID: 17416835
    [Abstract] [Full Text] [Related]

  • 5. Comparison of microvascular permeability measurements, K(trans), determined with conventional steady-state T1-weighted and first-pass T2*-weighted MR imaging methods in gliomas and meningiomas.
    Cha S, Yang L, Johnson G, Lai A, Chen MH, Tihan T, Wendland M, Dillon WP.
    AJNR Am J Neuroradiol; 2006 Feb; 27(2):409-17. PubMed ID: 16484420
    [Abstract] [Full Text] [Related]

  • 6. Assesment of perfusion in glial tumors with arterial spin labeling; comparison with dynamic susceptibility contrast method.
    Cebeci H, Aydin O, Ozturk-Isik E, Gumus C, Inecikli F, Bekar A, Kocaeli H, Hakyemez B.
    Eur J Radiol; 2014 Oct; 83(10):1914-9. PubMed ID: 25087109
    [Abstract] [Full Text] [Related]

  • 7. Correlation of Tumor Immunohistochemistry with Dynamic Contrast-Enhanced and DSC-MRI Parameters in Patients with Gliomas.
    Nguyen TB, Cron GO, Bezzina K, Perdrizet K, Torres CH, Chakraborty S, Woulfe J, Jansen GH, Thornhill RE, Zanette B, Cameron IG.
    AJNR Am J Neuroradiol; 2016 Dec; 37(12):2217-2223. PubMed ID: 27585700
    [Abstract] [Full Text] [Related]

  • 8. Enhancing fraction in glioma and its relationship to the tumoral vascular microenvironment: A dynamic contrast-enhanced MR imaging study.
    Mills SJ, Soh C, O'Connor JP, Rose CJ, Buonaccorsi G, Cheung S, Zhao S, Parker GJ, Jackson A.
    AJNR Am J Neuroradiol; 2010 Apr; 31(4):726-31. PubMed ID: 20019100
    [Abstract] [Full Text] [Related]

  • 9. Multimodal MRI in the characterization of glial neoplasms: the combined role of single-voxel MR spectroscopy, diffusion imaging and echo-planar perfusion imaging.
    Zonari P, Baraldi P, Crisi G.
    Neuroradiology; 2007 Oct; 49(10):795-803. PubMed ID: 17619871
    [Abstract] [Full Text] [Related]

  • 10. Glial tumor grading and outcome prediction using dynamic spin-echo MR susceptibility mapping compared with conventional contrast-enhanced MR: confounding effect of elevated rCBV of oligodendrogliomas [corrected].
    Lev MH, Ozsunar Y, Henson JW, Rasheed AA, Barest GD, Harsh GR, Fitzek MM, Chiocca EA, Rabinov JD, Csavoy AN, Rosen BR, Hochberg FH, Schaefer PW, Gonzalez RG.
    AJNR Am J Neuroradiol; 2004 Feb; 25(2):214-21. PubMed ID: 14970020
    [Abstract] [Full Text] [Related]

  • 11. Perfusion MRI (dynamic susceptibility contrast imaging) with different measurement approaches for the evaluation of blood flow and blood volume in human gliomas.
    Thomsen H, Steffensen E, Larsson EM.
    Acta Radiol; 2012 Feb 01; 53(1):95-101. PubMed ID: 22114021
    [Abstract] [Full Text] [Related]

  • 12. Comparison of region-of-interest analysis with three different histogram analysis methods in the determination of perfusion metrics in patients with brain gliomas.
    Young R, Babb J, Law M, Pollack E, Johnson G.
    J Magn Reson Imaging; 2007 Oct 01; 26(4):1053-63. PubMed ID: 17896374
    [Abstract] [Full Text] [Related]

  • 13. Abnormalities in the recirculation phase of contrast agent bolus passage in cerebral gliomas: comparison with relative blood volume and tumor grade.
    Jackson A, Kassner A, Annesley-Williams D, Reid H, Zhu XP, Li KL.
    AJNR Am J Neuroradiol; 2002 Jan 01; 23(1):7-14. PubMed ID: 11827869
    [Abstract] [Full Text] [Related]

  • 14. Dynamic contrast-enhanced susceptibility-weighted perfusion imaging of intracranial tumors: a study using a 3T MR scanner.
    Sentürk S, Oğuz KK, Cila A.
    Diagn Interv Radiol; 2009 Mar 01; 15(1):3-12. PubMed ID: 19263367
    [Abstract] [Full Text] [Related]

  • 15. Characterization of a first-pass gradient-echo spin-echo method to predict brain tumor grade and angiogenesis.
    Schmainda KM, Rand SD, Joseph AM, Lund R, Ward BD, Pathak AP, Ulmer JL, Badruddoja MA, Krouwer HG.
    AJNR Am J Neuroradiol; 2004 Oct 01; 25(9):1524-32. PubMed ID: 15502131
    [Abstract] [Full Text] [Related]

  • 16. Facing contrast-enhancing gliomas: perfusion MRI in grade III and grade IV gliomas according to tumor area.
    Di Stefano AL, Bergsland N, Berzero G, Farina L, Rognone E, Gastaldi M, Aquino D, Frati A, Tomasello F, Ceroni M, Marchioni E, Bastianello S.
    Biomed Res Int; 2014 Oct 01; 2014():154350. PubMed ID: 24800207
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Histogram analysis of T2*-based pharmacokinetic imaging in cerebral glioma grading.
    Liu HS, Chiang SW, Chung HW, Tsai PH, Hsu FT, Cho NY, Wang CY, Chou MC, Chen CY.
    Comput Methods Programs Biomed; 2018 Mar 01; 155():19-27. PubMed ID: 29512499
    [Abstract] [Full Text] [Related]

  • 20. Histogram analysis of MR imaging-derived cerebral blood volume maps: combined glioma grading and identification of low-grade oligodendroglial subtypes.
    Emblem KE, Scheie D, Due-Tonnessen P, Nedregaard B, Nome T, Hald JK, Beiske K, Meling TR, Bjornerud A.
    AJNR Am J Neuroradiol; 2008 Oct 01; 29(9):1664-70. PubMed ID: 18583405
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.